Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 52 | 2014 | 354 | 3.820 |
Why?
|
| Trachea | 46 | 2014 | 293 | 2.740 |
Why?
|
| Muscle Contraction | 36 | 2014 | 283 | 1.880 |
Why?
|
| Acetylcholine | 21 | 2008 | 176 | 1.270 |
Why?
|
| Bronchi | 8 | 2004 | 229 | 0.700 |
Why?
|
| Depsipeptides | 3 | 2010 | 29 | 0.590 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2008 | 76 | 0.570 |
Why?
|
| In Vitro Techniques | 28 | 2004 | 989 | 0.550 |
Why?
|
| Thiazoles | 3 | 2008 | 131 | 0.550 |
Why?
|
| Dogs | 28 | 2014 | 685 | 0.520 |
Why?
|
| Immunization | 4 | 1994 | 158 | 0.430 |
Why?
|
| Thiazolidines | 3 | 2008 | 17 | 0.400 |
Why?
|
| Myosins | 6 | 2008 | 90 | 0.370 |
Why?
|
| Electric Stimulation | 14 | 2003 | 347 | 0.360 |
Why?
|
| Receptors, Muscarinic | 4 | 2000 | 49 | 0.350 |
Why?
|
| Isometric Contraction | 7 | 2003 | 38 | 0.330 |
Why?
|
| Bronchoconstriction | 7 | 2012 | 55 | 0.320 |
Why?
|
| Respiratory Hypersensitivity | 5 | 1997 | 41 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 222 | 0.310 |
Why?
|
| Actin Cytoskeleton | 3 | 2009 | 192 | 0.310 |
Why?
|
| Potassium Chloride | 10 | 2003 | 87 | 0.300 |
Why?
|
| Asthma | 10 | 2009 | 955 | 0.300 |
Why?
|
| Animals | 56 | 2014 | 26582 | 0.300 |
Why?
|
| Calcium | 4 | 2000 | 1156 | 0.290 |
Why?
|
| Immunization, Passive | 2 | 1997 | 71 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2008 | 1961 | 0.280 |
Why?
|
| Acetylcholinesterase | 5 | 1992 | 47 | 0.270 |
Why?
|
| Capsaicin | 2 | 1995 | 44 | 0.260 |
Why?
|
| Physostigmine | 6 | 1997 | 19 | 0.260 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2012 | 77 | 0.240 |
Why?
|
| Airway Obstruction | 4 | 2008 | 109 | 0.220 |
Why?
|
| Stress, Mechanical | 7 | 2008 | 248 | 0.220 |
Why?
|
| Indomethacin | 4 | 2012 | 59 | 0.210 |
Why?
|
| Serotonin | 7 | 1998 | 218 | 0.210 |
Why?
|
| Antigens, Helminth | 2 | 1998 | 22 | 0.200 |
Why?
|
| Atropine | 5 | 2000 | 59 | 0.200 |
Why?
|
| Cats | 3 | 1998 | 303 | 0.190 |
Why?
|
| Muscle Tonus | 3 | 1997 | 19 | 0.190 |
Why?
|
| Cholinesterase Inhibitors | 3 | 1997 | 45 | 0.180 |
Why?
|
| Myosin Light Chains | 4 | 2003 | 29 | 0.180 |
Why?
|
| Muscle Relaxation | 2 | 1997 | 18 | 0.170 |
Why?
|
| Guinea Pigs | 5 | 1997 | 171 | 0.160 |
Why?
|
| Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 1997 | 3 | 0.160 |
Why?
|
| Prostaglandin Antagonists | 1 | 1997 | 7 | 0.160 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1997 | 5 | 0.160 |
Why?
|
| Xanthones | 1 | 1997 | 11 | 0.160 |
Why?
|
| Dinoprostone | 1 | 1997 | 69 | 0.150 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 23 | 0.150 |
Why?
|
| Respiratory Muscles | 1 | 1997 | 13 | 0.150 |
Why?
|
| Cyclosporine | 1 | 1998 | 234 | 0.150 |
Why?
|
| Receptors, Tachykinin | 1 | 1995 | 9 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2014 | 782 | 0.130 |
Why?
|
| Dystrophin | 1 | 2014 | 21 | 0.130 |
Why?
|
| Phosphorylation | 7 | 2010 | 1106 | 0.120 |
Why?
|
| Swine | 9 | 2002 | 555 | 0.120 |
Why?
|
| Histamine | 7 | 1998 | 126 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 26 | 0.110 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 31 | 0.110 |
Why?
|
| Kinetics | 7 | 2001 | 1513 | 0.110 |
Why?
|
| Lymphatic System | 1 | 1993 | 53 | 0.110 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2012 | 22 | 0.110 |
Why?
|
| Caveolin 1 | 1 | 2012 | 20 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1993 | 72 | 0.110 |
Why?
|
| Methacholine Chloride | 6 | 2014 | 64 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 100 | 0.110 |
Why?
|
| Lung | 3 | 2014 | 1170 | 0.110 |
Why?
|
| Parasympathetic Nervous System | 2 | 1991 | 33 | 0.100 |
Why?
|
| Male | 21 | 2008 | 40966 | 0.100 |
Why?
|
| Respiratory System | 3 | 2014 | 116 | 0.100 |
Why?
|
| Pollen | 2 | 1993 | 80 | 0.090 |
Why?
|
| Epithelium | 3 | 1997 | 319 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2014 | 132 | 0.090 |
Why?
|
| Ascaris suum | 3 | 1998 | 10 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 101 | 0.090 |
Why?
|
| Isotonic Contraction | 1 | 1989 | 2 | 0.090 |
Why?
|
| Isoproterenol | 4 | 1994 | 59 | 0.090 |
Why?
|
| Hypersensitivity | 2 | 2006 | 154 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2014 | 2818 | 0.080 |
Why?
|
| Blood Proteins | 2 | 2000 | 144 | 0.080 |
Why?
|
| Respiratory Mechanics | 2 | 2007 | 102 | 0.080 |
Why?
|
| Aerosols | 3 | 2008 | 44 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1988 | 16 | 0.080 |
Why?
|
| Inflammation | 1 | 1993 | 920 | 0.080 |
Why?
|
| Ovalbumin | 4 | 1994 | 109 | 0.080 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 76 | 0.080 |
Why?
|
| Pirenzepine | 2 | 2000 | 8 | 0.080 |
Why?
|
| Vasoconstriction | 2 | 2006 | 93 | 0.080 |
Why?
|
| Steroids | 1 | 2008 | 177 | 0.080 |
Why?
|
| Aging | 6 | 2008 | 691 | 0.070 |
Why?
|
| Parasympatholytics | 2 | 2000 | 18 | 0.070 |
Why?
|
| Flax | 1 | 2006 | 1 | 0.070 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 32 | 0.070 |
Why?
|
| Environment | 1 | 2008 | 219 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 307 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2006 | 128 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 296 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 161 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 154 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 181 | 0.060 |
Why?
|
| Oxazoles | 2 | 2003 | 19 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 152 | 0.060 |
Why?
|
| Myosin Heavy Chains | 3 | 2014 | 88 | 0.060 |
Why?
|
| Bradykinin | 2 | 2000 | 46 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2004 | 217 | 0.060 |
Why?
|
| Female | 12 | 2012 | 44533 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2003 | 44 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 83 | 0.050 |
Why?
|
| Arachidonic Acid | 2 | 2012 | 63 | 0.050 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 639 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 350 | 0.050 |
Why?
|
| Freezing | 1 | 2001 | 33 | 0.050 |
Why?
|
| Airway Resistance | 3 | 1995 | 69 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2003 | 579 | 0.050 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 12 | 0.050 |
Why?
|
| Fura-2 | 1 | 2000 | 22 | 0.050 |
Why?
|
| Diamines | 1 | 2000 | 11 | 0.050 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2000 | 12 | 0.050 |
Why?
|
| Macrocyclic Compounds | 1 | 2000 | 7 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2000 | 17 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2000 | 55 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 122 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 3092 | 0.040 |
Why?
|
| Muscle Development | 4 | 1992 | 41 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2000 | 182 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2014 | 3241 | 0.040 |
Why?
|
| Phenotype | 2 | 2008 | 2378 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1924 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 242 | 0.040 |
Why?
|
| Piperidines | 1 | 2000 | 181 | 0.040 |
Why?
|
| Potassium | 3 | 1987 | 281 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1998 | 14 | 0.040 |
Why?
|
| Tidal Volume | 2 | 2010 | 53 | 0.040 |
Why?
|
| Polyamines | 1 | 1998 | 32 | 0.040 |
Why?
|
| Immunoglobulin E | 2 | 1997 | 144 | 0.040 |
Why?
|
| Norepinephrine | 2 | 1989 | 167 | 0.040 |
Why?
|
| Humans | 11 | 2009 | 86644 | 0.040 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 1997 | 3 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1998 | 92 | 0.040 |
Why?
|
| Mast Cells | 1 | 1998 | 92 | 0.040 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 1997 | 3 | 0.040 |
Why?
|
| Iloprost | 1 | 1997 | 15 | 0.040 |
Why?
|
| Xanthenes | 1 | 1997 | 23 | 0.040 |
Why?
|
| Intradermal Tests | 1 | 1997 | 3 | 0.040 |
Why?
|
| Eosinophils | 1 | 1998 | 194 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 1997 | 68 | 0.040 |
Why?
|
| Acidosis, Respiratory | 1 | 1977 | 7 | 0.040 |
Why?
|
| Carbon Dioxide | 2 | 1977 | 188 | 0.040 |
Why?
|
| Cattle | 2 | 1998 | 376 | 0.040 |
Why?
|
| Allergens | 1 | 1997 | 179 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2012 | 40 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 125 | 0.040 |
Why?
|
| Tromethamine | 1 | 1995 | 4 | 0.030 |
Why?
|
| Time Factors | 4 | 1994 | 5210 | 0.030 |
Why?
|
| Extracellular Space | 2 | 1991 | 90 | 0.030 |
Why?
|
| Cyproheptadine | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cat Diseases | 1 | 1995 | 20 | 0.030 |
Why?
|
| Drug Interactions | 2 | 1993 | 248 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 11 | 0.030 |
Why?
|
| Peptides | 1 | 1998 | 639 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 50 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1995 | 912 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 134 | 0.030 |
Why?
|
| Propranolol | 1 | 1994 | 45 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1753 | 0.030 |
Why?
|
| Mice | 4 | 2012 | 11352 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1993 | 10 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 63 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 262 | 0.030 |
Why?
|
| Amides | 2 | 2003 | 60 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 425 | 0.030 |
Why?
|
| Anaphylaxis | 2 | 1991 | 33 | 0.030 |
Why?
|
| Glucose | 1 | 1995 | 638 | 0.030 |
Why?
|
| Contractile Proteins | 2 | 1999 | 54 | 0.030 |
Why?
|
| Androstadienes | 2 | 2003 | 72 | 0.030 |
Why?
|
| Calcium Signaling | 2 | 2004 | 129 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 134 | 0.030 |
Why?
|
| Parasympathomimetics | 1 | 1992 | 8 | 0.030 |
Why?
|
| Antigens | 1 | 1993 | 228 | 0.030 |
Why?
|
| Immunity, Active | 1 | 1991 | 9 | 0.030 |
Why?
|
| Verapamil | 1 | 1991 | 48 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 1991 | 39 | 0.020 |
Why?
|
| Microcomputers | 1 | 1991 | 26 | 0.020 |
Why?
|
| Pyridines | 2 | 2003 | 310 | 0.020 |
Why?
|
| Endotoxins | 1 | 1990 | 36 | 0.020 |
Why?
|
| Nitroprusside | 2 | 2006 | 32 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1991 | 203 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 347 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 33 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1990 | 231 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 290 | 0.020 |
Why?
|
| Smooth Muscle Myosins | 1 | 2009 | 5 | 0.020 |
Why?
|
| Nitriles | 1 | 2010 | 149 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1989 | 72 | 0.020 |
Why?
|
| Oxygen | 1 | 1994 | 726 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 36 | 0.020 |
Why?
|
| Bronchial Spasm | 2 | 1986 | 16 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1990 | 435 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 669 | 0.020 |
Why?
|
| Tyramine | 1 | 1988 | 4 | 0.020 |
Why?
|
| Plethysmography | 1 | 2008 | 18 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2008 | 24 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 79 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1988 | 34 | 0.020 |
Why?
|
| Carbachol | 1 | 1987 | 34 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1990 | 597 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 229 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2008 | 199 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 136 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 1986 | 239 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2006 | 27 | 0.020 |
Why?
|
| Receptors, Histamine | 1 | 1986 | 5 | 0.020 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 12 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 23 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1986 | 55 | 0.020 |
Why?
|
| Myofibrils | 1 | 1986 | 23 | 0.020 |
Why?
|
| Sarcomeres | 1 | 1986 | 23 | 0.020 |
Why?
|
| Bronchial Diseases | 1 | 1986 | 12 | 0.020 |
Why?
|
| Calmodulin | 1 | 1986 | 50 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2006 | 130 | 0.020 |
Why?
|
| Triglycerides | 1 | 2006 | 232 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 966 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2006 | 127 | 0.020 |
Why?
|
| Rabbits | 1 | 2006 | 636 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 1986 | 153 | 0.020 |
Why?
|
| Aorta | 1 | 2006 | 280 | 0.020 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2004 | 2 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 6 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1995 | 33 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 306 | 0.020 |
Why?
|
| Elasticity | 1 | 2004 | 94 | 0.020 |
Why?
|
| Cholesterol | 1 | 2006 | 356 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1986 | 457 | 0.020 |
Why?
|
| Tetany | 1 | 2003 | 1 | 0.010 |
Why?
|
| Marine Toxins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Physiology | 1 | 1983 | 16 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1920 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2003 | 18 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 75 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 458 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 111 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 428 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1994 | 510 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 2001 | 25 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 159 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 401 | 0.010 |
Why?
|
| Solutions | 1 | 2001 | 85 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 451 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 379 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1540 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1683 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 937 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 20 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1986 | 2232 | 0.010 |
Why?
|
| Polyelectrolytes | 1 | 1998 | 6 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 1998 | 20 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1749 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1998 | 39 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1999 | 132 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1135 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1978 | 26 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1999 | 281 | 0.010 |
Why?
|
| Cell Communication | 1 | 1999 | 194 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1977 | 493 | 0.010 |
Why?
|
| Middle Aged | 1 | 1994 | 25028 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1974 | 50 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1995 | 239 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 91 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 83 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1999 | 1458 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1991 | 26 | 0.010 |
Why?
|
| Bronchography | 1 | 1991 | 11 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 1991 | 15 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1990 | 35 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1219 | 0.010 |
Why?
|
| Vasodilation | 1 | 1990 | 96 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1989 | 15 | 0.010 |
Why?
|
| Bucladesine | 1 | 1989 | 13 | 0.010 |
Why?
|
| Colforsin | 1 | 1989 | 74 | 0.010 |
Why?
|
| Rats | 1 | 1994 | 3990 | 0.000 |
Why?
|
| Age Factors | 1 | 1991 | 1851 | 0.000 |
Why?
|
| Methylhistamines | 1 | 1980 | 1 | 0.000 |
Why?
|
| Pyrilamine | 1 | 1980 | 1 | 0.000 |
Why?
|
| Metiamide | 1 | 1980 | 2 | 0.000 |
Why?
|
| Receptors, Histamine H2 | 1 | 1980 | 5 | 0.000 |
Why?
|
| Rana temporaria | 1 | 1978 | 1 | 0.000 |
Why?
|
| Rana pipiens | 1 | 1978 | 11 | 0.000 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1978 | 10 | 0.000 |
Why?
|
| Anura | 1 | 1978 | 19 | 0.000 |
Why?
|
| Oxidative Phosphorylation | 1 | 1978 | 49 | 0.000 |
Why?
|
| Muscles | 1 | 1978 | 194 | 0.000 |
Why?
|
| Proteins | 1 | 1978 | 777 | 0.000 |
Why?
|